27Nov 2022
Incidence and Clinical Correlates of De‐novo Aortic Regurgitation with a Fully Magnetically Levitated LVAD: A MOMENTUM3 Trial Portfolio Analysis

Incidence and Clinical Correlates of De‐novo Aortic Regurgitation with a Fully Magnetically Levitated LVAD: A MOMENTUM3 Trial Portfolio Analysis

AR incidence at 2-years was analyzed in the randomized PT and validated in the first 1000 implanted patients of the CAP. Patients with concomitant/prior aortic valve surgery or without baseline or post-implant echocardiograms were excluded from this analysis. AR severity was assessed qualitatively by site-adjudicated echocardiograms (Significant AR was defined as moderate or severe grade on echocardiogram). Of 1028 patients enrolled in the PT, 918 were eligible for inclusion in this analysis (HM3=465, HMII=453). At 2-years of LVAD support, freedom from significant AR was greater in the HM3 (92%) than HMII (82%) (HR 0.45, 95% CI 0.27–0.75, p<0.01). Of 907 patients analyzed from the first 1000 implanted CAP patients, the rate of freedom from significant Survival free of urgent transplant or AR corrective procedure similar between HM3 patients with and without significant de-novo AR.

  • #cardiology

Like

Save

Share